Czech Republic appeals plasma award

The Czech Republic has applied to annul a US$650 million treaty award holding it liable for frustrating the investment of a blood plasma supplier and its owner, including through the state's actions in an earlier contractual arbitration, while revealing the investors had sought up to US$2.2 billion.

Get unlimited access to all Global Arbitration Review content